Laura Korsakova

Laura Korsakova is the Co-founder and CEO at Psylink, a biotechnology company focused on advancing nature-based molecule biosynthesis through synthetic biology and metabolic engineering. Before founding Psylink, Laura conducted pharmacology research in academia and worked in a cell therapy-based startup, where she helped bring advanced therapy medicinal products to market for oncology patients. Now, she is dedicated to advancing novel psychedelic-inspired molecules through preclinical and clinical development for mental health disorders.